48 results
Page 2 of 3
6-K
EX-99.1
f91v5g04yutvg u2irx
9 Feb 21
SciSparc Initiates Commercial Production of its CannAmide™ Pills
8:36am
6-K
EX-99.1
lex6u woyf
5 Jan 21
Therapix Biosciences and Cyntar Ventures Entered a Non-Binding Letter of Intent for the Distribution of TheraPEA in Canada
9:12am
424B4
9qcp8 fmzy4
20 Nov 20
Prospectus supplement with pricing info
4:43pm
FWP
2xqn24mx7ut4tr4
5 Nov 20
Free writing prospectus
5:11pm
F-1/A
r0ez2klnct3 73p
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
FWP
sy431n
21 Oct 20
Free writing prospectus
7:26am
F-1/A
rbwx f2g7zg
20 Oct 20
Registration statement (foreign) (amended)
9:57pm
F-1/A
u344y2vrsrn
9 Oct 20
Registration statement (foreign) (amended)
12:00am
6-K
EX-99.2
6oarmo1 op60
9 Oct 20
Interim Consolidated Financial Statements
12:00am
6-K
EX-99.1
y0bzn
16 Sep 20
Developing cannabinoid based pharmaceuticals Corporate Presentation • September 2020
7:11am
F-1
qcgxx xywo9
8 Sep 20
Registration statement (foreign)
5:31pm
6-K
EX-99.2
yx56 eljyhcsv
22 Apr 20
Therapix Biosciences Announces Appointment of New CEO
5:30pm
424B4
n9eogfhkcu y7gw
2 Apr 20
Prospectus supplement with pricing info
5:28pm
F-1/A
uxte5wsz6p7w08xriyg
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
7mgpp2
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
b3rlx3
26 Mar 20
Registration statement (foreign) (amended)
12:00am
F-1/A
ae3pa 7ynehkilzd27
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
424B5
07jw7 svgyi59
5 Dec 19
Prospectus supplement for primary offering
5:29pm
6-K
EX-99.1
hr2tfix ok
31 Jul 19
Therapix Biosciences Announces Canadian Product License Issuance for TheraPEA (CannAmide™), a Non-Opiate Based Pain Management Supplement
4:03pm